SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001213900-19-027161
Filing Date
2019-12-30
Accepted
2019-12-30 14:25:08
Documents
11
Effectiveness Date
2019-12-30

Document Format Files

Seq Description Document Type Size
1 DEFM14A defm14a1219_advansource.htm DEFM14A 2522735
2 GRAPHIC sig_001.jpg GRAPHIC 35891
3 GRAPHIC kingsdale_logo.jpg GRAPHIC 33596
4 GRAPHIC proxy_001.jpg GRAPHIC 1005950
5 GRAPHIC proxy_002.jpg GRAPHIC 429466
6 GRAPHIC miruscapital_logo.jpg GRAPHIC 35667
7 GRAPHIC mcpp.jpg GRAPHIC 54945
8 GRAPHIC mitsubishi_logo.jpg GRAPHIC 41831
9 GRAPHIC mcpp1.jpg GRAPHIC 54937
10 GRAPHIC mitsubishi_logo1.jpg GRAPHIC 41837
11 GRAPHIC mitsubishi_logo2.jpg GRAPHIC 41837
  Complete submission text file 0001213900-19-027161.txt   4934734
Mailing Address 229 ANDOVER STREET WILMINGTON MA 01887
Business Address 229 ANDOVER STREET WILMINGTON MA 01887 978-657-0075
AdvanSource Biomaterials Corp (Filer) CIK: 0001011060 (see all company filings)

IRS No.: 043186647 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEFM14A | Act: 34 | File No.: 001-11737 | Film No.: 191316173
SIC: 3841 Surgical & Medical Instruments & Apparatus